Cetirizine dihydrochloride 83881-52-1 99%

Supriya Lifescience Ltd. is a cGMP compliant API Manufacturing Organization with leadership position across key and niche products.
Supriya Lifescience Limited headquartered in Mumbai, India is a public listed generic pharmaceutical company established in 1987 dedicated to developing, commercializing APIs & FDFs to treat patients with various diseases and infections. The API facility located at Lote, Maharashtra, India is multiple times USFDA, EDQM/EUGMP approved, and Health Canada approved whereas the Formulation facility located at Ambernath, Mumbai, India is EUGMP compliant.

Supriya Lifescience Ltd. has a well-established presence in API Manufacturing with focus in products of various therapeutic segments like – Anti-Histamine, Anti-Allergics, Vitamins, Anaesthetics, Anti- Asthmatics etc.

We take pride in setting the products, processes and the systems as per the industry standards and in making continuous improvement to deliver quality products. Our facility is spread across an area of 47,000 sq.m. with delineated areas for warehouse, QA, QC, R & D, production and finished products (dedicated blocks for different therapeutic segments). The plant has current capacity of 550 KL and supported with multiple clean rooms for finished products. As a part of our capacity expansion plan, our capacity would be approximately 1000+ KL by 2024.